Literature DB >> 9557862

Obstetric and perinatal outcome after oocyte donation: comparison with in-vitro fertilization pregnancies.

V Söderström-Anttila1, A Tiitinen, T Foudila, O Hovatta.   

Abstract

The obstetric and perinatal outcome in 51 oocyte donation pregnancies (61 infants) was compared with that of a control group of standard in-vitro fertilization (IVF) patients (97 pregnancies, 126 infants). The oocyte recipients (mean +/- SD age 33.5+/-4.7 years) included 39 women with ovarian failure and 12 women with functioning ovaries. In oocyte recipients, first trimester bleeding (53%) occurred significantly more often than in IVF mothers (31%, P < 0.01). Pregnancy-induced hypertension was observed in 31% of oocyte recipients compared with 14% in IVF mothers (P < 0.05). There was no difference in the duration of pregnancies or in the preterm delivery rate between the two groups. When restricting analysis to singleton pregnancies, 63% of oocyte recipients were hospitalized in the antenatal period compared with 29% in the IVF group (P < 0.001). The Caesarean section rate was 57% in the oocyte donation group and 37% in the IVF group (P < 0.05). Birthweight in singleton pregnancies was similar in both groups. The perinatal mortality rate was 3.3% in the oocyte donation group and 0% in the IVF group. In conclusion, oocyte donation pregnancies are associated with an increased risk compared with IVF pregnancies, but the complications are usually manageable and most oocyte recipients experience a good pregnancy outcome.

Entities:  

Mesh:

Year:  1998        PMID: 9557862     DOI: 10.1093/humrep/13.2.483

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  22 in total

Review 1.  Cardiovascular disease and primary ovarian insufficiency.

Authors:  Melissa Wellons
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

Review 2.  FSH Actions and Pregnancy: Looking Beyond Ovarian FSH Receptors.

Authors:  Julie A W Stilley; Deborah L Segaloff
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

3.  Hypertensive disorders of pregnancy and infertility treatment: a population-based survey among United States women.

Authors:  Brent C Monseur; Jerrine R Morris; Heather S Hipp; Vincenzo Berghella
Journal:  J Assist Reprod Genet       Date:  2019-05-27       Impact factor: 3.412

4.  Oocyte donation: a risk factor for pregnancy-induced hypertension: a meta-analysis and case series.

Authors:  Ulrich Pecks; Nicolai Maass; Joseph Neulen
Journal:  Dtsch Arztebl Int       Date:  2011-01-21       Impact factor: 5.594

Review 5.  A new era in reproductive medicine: consequences of third-party oocyte donation for maternal and fetal health.

Authors:  Shigeru Saito; Yasushi Nakabayashi; Akitoshi Nakashima; Tomoko Shima; Osamu Yoshino
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

Review 6.  From victim to survivor to thriver: helping women with primary ovarian insufficiency integrate recovery, self-management, and wellness.

Authors:  Evelina Weidman Sterling; Lawrence M Nelson
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

7.  Is the risk of preeclampsia higher in donor oocyte pregnancies? A systematic review and meta-analysis.

Authors:  Juan Enrique Schwarze; Paula Borda; Pamela Vásquez; Carolina Ortega; Sonia Villa; Javier A Crosby; Ricardo Pommer
Journal:  JBRA Assist Reprod       Date:  2018-03-01

8.  Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies.

Authors:  Kirk P Conrad; Valerie L Baker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-10-24       Impact factor: 3.619

9.  Gestational hypertension in pregnancies supported by infertility treatments: role of infertility, treatments, and multiple gestations.

Authors:  Sonia Hernández-Díaz; Martha M Werler; Allen A Mitchell
Journal:  Fertil Steril       Date:  2007-04-20       Impact factor: 7.329

10.  Maternal death after oocyte donation at high maternal age: case report.

Authors:  Joke M Schutte; Nico W E Schuitemaker; Eric A P Steegers; Jos van Roosmalen
Journal:  Reprod Health       Date:  2008-12-30       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.